Tolerance Bio, Inc.

Thymmune

This biotechnology company develops scalable thymic cell therapies to restore immune function for patients with immunodeficiencies, autoimmune disorders, and transplant-related conditions.

Zag Bio

This biotechnology company develops thymus-targeted bifunctional antibodies that deliver antigens to induce immune tolerance in patients with autoimmune diseases such as type 1 diabetes.

Aboleris Pharma

This biopharmaceutical company develops immunomodulatory antibodies to treat autoimmune diseases and organ transplantation rejection for patients requiring restored immune tolerance.

Topas Therapeutics

This biotechnology company develops nanoparticle-based therapeutics that induce immune tolerance to treat patients with autoimmune diseases, allergies and anti-drug immune responses.

Toleranzia

This company develops drugs using an immune tolerance platform to treat patients with rare autoimmune diseases, such as myasthenia gravis.

ImmuneWorks

This biotechnology firm develops immune tolerance therapies and diagnostic tests for patients suffering from idiopathic pulmonary fibrosis and lung transplant rejection.

Apitope

Apitope develops antigen-specific peptide therapeutics to treat autoimmune diseases and allergies for patients requiring targeted immunotherapy and immune tolerance restoration.

GentiBio

GentiBio develops engineered regulatory T cell therapies to restore immune tolerance for patients with autoimmune, alloimmune, autoinflammatory and allergic diseases.